Dana-Farber patient Kate Beckett and Dr. Ursula Matulonis on Kate’s endometrial cancer treatment and the advancements of immunotherapy drugs at Dana-Farber

WEEI/NESN Jimmy Fund Radio-Telethon
Wednesday, August 21st
Kate Beckett had just gone through treatment for endometrial cancer when she began to feel leg pain—it was then she found out the cancer had spread to her hip. Several treatments failed before Kate went to Dana-Farber, where a new immunotherapy drug that had only been approved eight weeks prior began to work wonders. Kate and Dr. Ursula Matulonis talk to Dale and Keefe about Kate’s diagnosis and the immunotherapy research being done at Dana-Farber.